These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24465147)

  • 1. Zinc-triggered induction of tissue plasminogen activator and plasminogen in endothelial cells and pericytes.
    Cho MK; Sun ES; Kim YH
    Exp Neurobiol; 2013 Dec; 22(4):315-21. PubMed ID: 24465147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
    Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
    Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β.
    Park L; Zhou J; Koizumi K; Wang G; Anfray A; Ahn SJ; Seo J; Zhou P; Zhao L; Paul S; Anrather J; Iadecola C
    J Neurosci; 2020 Oct; 40(42):8160-8173. PubMed ID: 32928888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death.
    Kim HN; Kim TY; Yoon YH; Koh JY
    Brain Res; 2015 Dec; 1628(Pt B):317-326. PubMed ID: 26111647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator arrests Alzheimer's disease pathogenesis.
    Oh SB; Byun CJ; Yun JH; Jo DG; Carmeliet P; Koh JY; Lee JY
    Neurobiol Aging; 2014 Mar; 35(3):511-9. PubMed ID: 24126163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice.
    Uekawa K; Anfray A; Ahn SJ; Casey N; Seo J; Zhou P; Iadecola C; Park L
    Alzheimers Dement; 2024 Jul; 20(7):4572-4582. PubMed ID: 38899570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-triggered induction of tissue plasminogen activator by brain-derived neurotrophic factor and metalloproteinases.
    Hwang IY; Sun ES; An JH; Im H; Lee SH; Lee JY; Han PL; Koh JY; Kim YH
    J Neurochem; 2011 Sep; 118(5):855-63. PubMed ID: 21615740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
    Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms.
    Cacquevel M; Launay S; Castel H; Benchenane K; Chéenne S; Buée L; Moons L; Delacourte A; Carmeliet P; Vivien D
    Neurobiol Dis; 2007 Aug; 27(2):164-73. PubMed ID: 17566751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.
    Diaz A; Merino P; Guo JD; Yepes MA; McCann P; Katta T; Tong EM; Torre E; Rangaraju S; Yepes M
    J Neurosci; 2020 May; 40(21):4251-4263. PubMed ID: 32332118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
    de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.